title: [Does hypothyroidism potentialize muscular toxicity of fibrates?].
authors.forename: J R
authors.initials: JR
authors.lastname: Harlé
authors.forename: E
authors.initials: E
authors.lastname: Toussirot
authors.forename: P
authors.initials: P
authors.lastname: Disdier
authors.forename: M
authors.initials: M
authors.lastname: Drancourt
authors.forename: P J
authors.initials: PJ
authors.lastname: Weiller
mesh_terms: D000368:Aged; D001629:Bezafibrate / Q000009:adverse effects*; D002995:Clofibric Acid / Q000009:adverse effects / Q000031:analogs & derivatives*; D005260:Female; D058607:Fibric Acids; D006801:Humans; D000960:Hypolipidemic Agents / Q000009:adverse effects*; D007037:Hypothyroidism / Q000503:physiopathology*; D008875:Middle Aged; D009135:Muscular Diseases / Q000139:chemically induced*
chemical_list: D058607:Fibric Acids; D000960:Hypolipidemic Agents; D002995:Clofibric Acid; C019304:ciprofibrate; D001629:Bezafibrate
vernacular_title: L'hypothyroïdie potentialise-t-elle la toxicité musculaire des fibrates?